Development and validation of a respiratory syncytial virus multiplex immunoassay
Infection · 2024
DOI: 10.1007/s15010-024-02180-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection, 2024. Verfasst von Patrick Marsall und 14 weiteren Autor:innen. Beteiligte Einrichtung: NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Purpose
Respiratory syncytial virus (RSV) is one of the leading causes of severe respiratory disease in infants and adults. While vaccines and monoclonal therapeutic antibodies either are or will shortly become available, correlates of protection remain unclear. For this purpose, we developed an RSV multiplex immunoassay that analyses antibody titers toward the post-F, Nucleoprotein, and a diverse mix of G proteins.
Methods
A bead-based multiplex RSV immunoassay was developed, technically validated to standard FDA bioanalytical guidelines, and clinically validated using samples from human challenge studies. RSV antibody titers were then investigated in children aged under 2 and a population-based cohort.
Results
Technical and clinical validation showed outstanding performance, while methodological developments enabled identification of the subtype of previous infections through use of the diverse G proteins for approximately 50% of samples. As a proof of concept to show the suitability of the assay in serosurveillance studies, we then evaluated titer decay and age-dependent antibody responses within population cohorts.
Conclusion
Overall, the developed assay shows robust performance, is scalable, provides additional information on infection subtype, and is therefore ideally suited to be used in future population cohort studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
- Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
- German Centre for Infection Research (DZIF), TI BBD, Partner Site Hannover-Braunschweig, Braunschweig, Germany.
- Department of Infectious Disease, Imperial College London, London, UK.
- Department of Pediatric Neurology and Developmental Medicine, University Children's Hospital, Tübingen, Germany.
- Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Förderung
- Medical Research Council
- Wellcome Trust
- Horizon 2020 Framework Programme
- Initiative and Networking Fund of the Helmholtz Association of German Research Centres
- Bundesministerium für Bildung und Forschung
- Network University Medicine
- Initiative and Networking Fund of the Helmholtz Association
- Kwok Foundation
Zitieren
APA
Marsall, P., Fandrich, M., Griesbaum, J., Harries, M., Lange, B., RESPINOW Study Consortium, Ascough, S., Dayananda, P., Chiu, C., Remppis, J., Ganzenmueller, T., Renk, H., Strengert, M., Schneiderhan-Marra, N., & Dulovic, A. (2024). Development and validation of a respiratory syncytial virus multiplex immunoassay. Infection. https://doi.org/10.1007/s15010-024-02180-6
Vancouver
Marsall P, Fandrich M, Griesbaum J, Harries M, Lange B, RESPINOW Study Consortium, et al. Development and validation of a respiratory syncytial virus multiplex immunoassay. Infection. 2024. doi:10.1007/s15010-024-02180-6
BibTeX
@article{Marsall2024,
author = {Marsall, Patrick and Fandrich, Madeleine and Griesbaum, Johanna and Harries, Manuela and Lange, Berit and RESPINOW Study Consortium, RESPINOW Study Consortium and Ascough, Stephanie and Dayananda, Pete and Chiu, Christopher and Remppis, Jonathan and Ganzenmueller, Tina and Renk, Hanna and Strengert, Monika and Schneiderhan-Marra, Nicole and Dulovic, Alex},
title = {Development and validation of a respiratory syncytial virus multiplex immunoassay},
journal = {Infection},
year = {2024},
doi = {10.1007/s15010-024-02180-6}
}
EUVIMED